| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Unité de Recherches Hormones et Reproduction (R.N.T., J-F.S., C.V., E.M.), INSERM U135, Université Paris-Sud, Hôpital de Bicêtre APHP, 94275 Le Kremlin-Bicêtre, France; Reproductive Endocrinology Center (R.N.T., J-L.V., I.P., D.H.), University of California, San Francisco School of Medicine, San Francisco, California 94143; and Department of Obstetrics and Gynaecology (M.S.), Helsinki University Central Hospital, Haartmaninkatu 2, SF-00290 Helsinki, Finland
Address all correspondence and requests for reprints to: Robert N. Taylor, M.D., Ph.D., Reproductive Endocrinology Center, University of California, San Francisco School of Medicine, San Francisco, California 94143-0132.
One of the most abundant protein products of human secretory endometrium is glycodelin, a glycoprotein previously referred to as PP14. Although the precise function of this protein is unknown, its unique glycosylation pattern is believed to affect immunomodulatory activity during human embryonic implantation and inhibition of sperm-egg binding after ovulation. Having confirmed the expression of glycodelin in secretory endometrial glands, we used purified endometrial epithelial cell cultures to demonstrate the hormonal regulation of glycodelin synthesis and secretion. The findings were corroborated by transiently transfecting glycodelin gene promoter-reporter constructs into human epithelioid HeLa and Ishikawa cells. Our results indicate that glycodelin protein production by endometrial epithelial cells is directly up-regulated 4- to 9-fold by progestins and antiprogestins in vitro. Transcriptional regulation of the glycodelin gene promoter expressed in HeLa cells is progesterone receptor-dependent. As observed in the primary endometrial cells, progestins and antiprogestins both act as agonists on the in vitro expression of this endometrial gene. Our findings provide insight into the regulation of this abundant endometrial protein and raise interesting questions about the physical nature of the interaction of agonist- and antagonist-bound progesterone receptors with the glycodelin gene promoter.
This article has been cited by other articles:
![]() |
G. Weiss, L. T. Goldsmith, R. N. Taylor, D. Bellet, and H. S. Taylor Inflammation in Reproductive Disorders Reproductive Sciences, February 1, 2009; 16(2): 216 - 229. [Abstract] [PDF] |
||||
![]() |
M Seppala, H Koistinen, R Koistinen, L Hautala, P C Chiu, and W S Yeung Glycodelin in reproductive endocrinology and hormone-related cancer Eur. J. Endocrinol., February 1, 2009; 160(2): 121 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. M. van Mourik, N. S. Macklon, and C. J. Heijnen Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment J. Leukoc. Biol., January 1, 2009; 85(1): 4 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Uchida, T. Maruyama, K. Ohta, M. Ono, T. Arase, M. Kagami, H. Oda, T. Kajitani, H. Asada, and Y. Yoshimura Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation Hum. Reprod., October 1, 2007; 22(10): 2615 - 2622. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Burney, S. Talbi, A. E. Hamilton, K. C. Vo, M. Nyegaard, C. R. Nezhat, B. A. Lessey, and L. C. Giudice Gene Expression Analysis of Endometrium Reveals Progesterone Resistance and Candidate Susceptibility Genes in Women with Endometriosis Endocrinology, August 1, 2007; 148(8): 3814 - 3826. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C Jaffe, S. D Ferguson-Gottschall, W. Gao, C. Beam, and A. T Fazleabas Histone deacetylase inhibition and progesterone act synergistically to stimulate baboon glycodelin gene expression J. Mol. Endocrinol., March 1, 2007; 38(3): 401 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wahab, A.H. Taylor, J.H. Pringle, J. Thompson, and F. Al-Azzawi Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell Mol. Hum. Reprod., March 1, 2006; 12(3): 157 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Mueller, J.-L. Vigne, M. Streich, M. K. Tee, L. Raio, E. Dreher, N. A. Bersinger, and R. N. Taylor 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Increases Glycodelin Gene and Protein Expression in Human Endometrium J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4809 - 4815. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.D. Catalano, A. Yanaihara, A.L. Evans, D. Rocha, A. Prentice, S. Saidi, C.G. Print, D.S. Charnock-Jones, A.M. Sharkey, and S.K. Smith The effect of RU486 on the gene expression profile in an endometrial explant model Mol. Hum. Reprod., August 1, 2003; 9(8): 465 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.C. Jaffe, K.M. Donnelly, and A.T. Fazleabas The induction of baboon glycodelin expression by progesterone is not through Sp1 Mol. Hum. Reprod., January 1, 2003; 9(1): 35 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Seppala, R. N. Taylor, H. Koistinen, R. Koistinen, and E. Milgrom Glycodelin: A Major Lipocalin Protein of the Reproductive Axis with Diverse Actions in Cell Recognition and Differentiation Endocr. Rev., August 1, 2002; 23(4): 401 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Vigne, D. Hornung, M. D. Mueller, and R. N. Taylor Purification and Characterization of an Immunomodulatory Endometrial Protein, Glycodelin J. Biol. Chem., May 11, 2001; 276(20): 17101 - 17105. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Mueller, J.-L. Vigne, A. Minchenko, D. I. Lebovic, D. C. Leitman, and R. N. Taylor Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta PNAS, September 26, 2000; 97(20): 10972 - 10977. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |